Blue Owl Capital Holdings’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-266,033
| Closed | -$2.71M | – | 76 |
|
|
2025
Q1 | $2.71M | Buy |
266,033
+23,400
| +10% | +$238K | 0.87% | 28 |
|
|
2024
Q4 | $3.84M | Buy |
242,633
+120,000
| +98% | +$1.9M | 0.89% | 25 |
|
|
2024
Q3 | $7.12M | Sell |
122,633
-35,000
| -22% | -$2.03M | 1.37% | 19 |
|
|
2024
Q2 | $7.2M | Sell |
157,633
-15,000
| -9% | -$686K | 2% | 16 |
|
|
2024
Q1 | $11.4M | Sell |
172,633
-180,000
| -51% | -$11.9M | 2.28% | 13 |
|
|
2023
Q4 | $14M | Buy |
+352,633
| New | +$14M | 3.35% | 10 |
|